Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settingsJacqueline S. Garcia, Robert J. Soiffer, Benjamin Tomlinson et al.|Blood|2022Cited by 51
Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve SettingsJacqueline S. Garcia, Robert J. Soiffer, Yael Flamand et al.|Blood|2020Cited by 12